Five Prime Therapeutics Inc.

(FPRX) Trade

By |

Profile

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. Its is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.

Contact Information

Website: www.fiveprime.com
Email: ir@fiveprime.com
Main Phone: +1 415 365-5600
Address: 111 Oyster Point Boulevard
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Aron M. Knickerbocker
Employees: 216
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 12.09 $ -0.1 (-0.82%)
Last Price 12.09 Change $ -0.1 Change % -0.82 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 12.25 High 12.45 Low 11.63 Prev Close 12.19
Last Trade Volume 531,936 52 Wk Hi 24.82 52 Wk Low 10.35
Market Cap 428.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,465,722.00 EPS (TTM) -4.03 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 33
Number of Buys 1 16
Number of Sells 2 17
Net Activity 2078 39932
Last 10 Buys Shares
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Brian G. Atwood 1,000
Last 10 Sell Shares
William R. Ringo 1,000
William R. Ringo 1,000
William R. Ringo 1,000
William R. Ringo 1,000
William R. Ringo 1,000
William R. Ringo 1,000
Francis W. Sarena 1,000
William R. Ringo 1,000
Lewis T. Williams 1,000
Lewis T. Williams 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 58 58 58 58
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 38 38 38 34.83
Standard Deviation 17.01 17.01 17.01 17.08
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 1 1 1 1
Hold 2 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.17 1.17 1.14